Press release
Eye-Drop And Lubricants Market Insights Highlight Segment Expansion And Market Leadership
The eye-drop and lubricants market is on track for substantial expansion in the coming years, driven by rising demand for effective eye care products and innovations in delivery systems. With a growing focus on managing chronic eye conditions and catering to aging populations, this sector is evolving rapidly to meet diverse consumer needs. Let's explore the market size projections, key players, and emerging trends shaping this dynamic industry.Projected Growth of the Eye-Drop and Lubricants Market by 2030
The eye-drop and lubricants market is expected to reach $27.78 billion by 2030, growing at a compound annual growth rate (CAGR) of 5.1%. This anticipated growth stems from several factors, including surging demand for advanced ophthalmic care solutions, the expansion of online retail channels, heightened attention to chronic eye disease management, increasing adoption among elderly individuals, and escalating investment in ophthalmic research. Key trends influencing the market's trajectory include a rising preference for preservative-free eye lubricants, broader use of multi-dose delivery mechanisms, the growing popularity of combination eye care therapies, the proliferation of gel and ointment formulations, and a stronger emphasis on providing long-lasting relief.
The eye-drop and lubricants market size has grown strongly in recent years. It will grow from $21.63 billion in 2025 to $22.79 billion in 2026 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to increasing prevalence of eye disorders, expansion of self-medication practices, rising awareness of eye hygiene, growth of pharmacy retail networks, improved access to ophthalmic products.
Download a free sample of the eye-drop and lubricants market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24530&type=smp&utm_source=Open&utm_medium=Paid&utm_campaign=Aug_PR
Key Elements Fueling the Eye-Drop and Lubricants Market Expansion
One major force behind the market's growth is the increasing adoption of preservative-free eye lubricants, which are preferred for their safety and reduced irritation potential. These products appeal especially to patients with sensitive eyes or long-term usage requirements.
In addition, the integration of multi-dose delivery systems is gaining traction, making the application of eye drops more convenient and hygienic. This innovation improves patient compliance and overall user experience, further driving market expansion.
Top Players Influencing the Eye-Drop and Lubricants Industry
Several prominent companies are active players in this sector, including Bayer AG, Sanofi S.A., Novartis AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Alcon Inc., Bausch + Lomb Incorporated, Santen Pharmaceutical Co. Ltd., Nicox S.A., Scope Ophthalmics Ltd., Lenz Therapeutics Inc., Eyeris Vision Care Pvt. Ltd., Akums Drugs and Pharmaceuticals Ltd., Medtech Products Inc., Rohto Pharmaceutical Co. Ltd, Eyevance Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd., Johnson & Johnson Vision, Similasan Corporation, Sager Pharma Kft, Cipla Ltd., Ajanta Pharma Ltd., Intas Pharmaceuticals Ltd., FDC Ltd., Alkem Laboratories Ltd., and Entod Pharmaceuticals Ltd.
View the full eye-drop and lubricants market report:
https://www.thebusinessresearchcompany.com/report/eye-drop-and-lubricants-global-market-report?utm_source=Open&utm_medium=Paid&utm_campaign=Aug_PR
Strategic Acquisition by Nirma Group to Strengthen Ophthalmic Portfolio
In April 2023, India-based chemical giant Nirma Group acquired Stericon Pharma, an Indian pharmaceutical company specializing in sterile multipurpose contact lens cleaning solutions, eye drops, and eye lubricants. Although the financial details of the deal were not disclosed, this acquisition is part of Nirma's strategy to bolster its presence in the pharmaceutical sector, particularly within ophthalmic products and sterile manufacturing. The move complements Nirma's Aculife Healthcare vertical and supports its broader ambition to expand through further acquisitions in the pharma space.
Innovative Trends Shaping the Future of Eye-Drop and Lubricants Market
Pharmaceutical companies are increasingly focusing on developing novel formulations to address dry eye symptoms more effectively and respond to the growing demand for multifunctional ocular health products.
For example, vitamin D3-enriched lubricating eye drops are emerging as a promising innovation. These formulations combine vitamin D3 (cholecalciferol) with moisturizing agents to not only alleviate dry eye discomfort but also provide anti-inflammatory and immune-regulatory benefits.
Breakthrough Vitamin D3-Enriched Eye Drops Launched by Entod Pharmaceuticals
In May 2024, Indian pharmaceutical company Entod Pharmaceuticals introduced vitamin D3-enriched lubricating eye drops, marking a significant advancement in ocular health solutions. This prescription-only product improves ocular surface health, helps stabilize tears, and supports corneal wound healing. It is particularly relevant given the high prevalence of vitamin D deficiency in India, which has been linked to various eye disorders such as age-related macular degeneration and diabetic retinopathy.
Segmenting the Eye-Drop and Lubricants Market by Product Type, Application, and Distribution
The eye-drop and lubricants market is segmented into various categories, including:
1) By Type: Antibiotics, Hormones, Artificial Tears, and Other Types
2) By Formulation: Liquid, Ointment, Gel, and Spray
3) By Distribution Channel: Online Retail, Pharmacies, Supermarkets or Hypermarkets, and Specialty Stores
4) By Application: Eye Disease, Eye Care, and Other Uses
5) By End User: Hospitals, Clinics, Homecare, and Eyewear Centers
Further subcategories include:
- Antibiotics broken down into Broad-Spectrum Antibiotics, Fluoroquinolones, Aminoglycosides, and Macrolides
- Hormones divided between Corticosteroids and Non-Corticosteroid Hormones
- Artificial Tears classified as Preserved or Preservative-Free
- Other Types such as Antihistamines, Decongestants, Antiglaucoma Agents, and Immunomodulators
This detailed segmentation offers a comprehensive view of market offerings and consumer applications across the globe.
What's new in our 2026 market reports:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel dashboards
• Market hotspots infographics
• Key technologies and future trends
• Updated graphics and tables
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Eye-Drop And Lubricants Market Insights Highlight Segment Expansion And Market Leadership here
News-ID: 4607395 • Views: …
More Releases from The Business Research Company
Healthcare Environmental Services Market Report 2026 Market Outlook Supported By …
The healthcare environmental services sector is poised for significant expansion as hospitals and medical facilities increasingly prioritize cleanliness, safety, and infection control. With technological advancements and a greater focus on sustainable and automated solutions, this market is set to undergo transformative growth in the coming years. Let's explore the current market size, driving factors, key players, prevailing trends, and segment-wise outlook of this important industry.
Healthcare Environmental Services Market Size and…
Gyneco-Obstetric Ultrasound Systems Market Analysis Highlights Growth To $4.2 Bi …
The gyneco-obstetric ultrasound systems market is on track for significant expansion as healthcare technologies continue to advance and demands for specialized diagnostic tools increase. This sector is gaining momentum due to several factors, including technological progress and a greater emphasis on maternal health monitoring, setting the stage for notable developments by 2030.
Projected Market Value and Growth Trajectory of the Gyneco-Obstetric Ultrasound Systems Market
The market for gyneco-obstetric ultrasound systems…
Healthcare EDI Market Insights Highlight Segment Expansion And Market Leadership
The healthcare electronic data interchange (EDI) market is on track for significant expansion as the industry increasingly embraces digital transformation to streamline operations and enhance data accuracy. With growing demands for automation and interoperability in healthcare systems, this market is set to experience remarkable growth in the coming years. Let's explore the market's size projections, influential players, and emerging trends shaping its future.
Forecasted Market Size of the Healthcare EDI Market…
Gut Microbiota Market Study Highlights How Industry Demand Is Evolving
The gut microbiota market is gaining significant attention as awareness of gut health and its impact on overall wellness continues to rise. Innovations in therapeutics, diagnostics, and nutrition are driving momentum, making this sector one to watch in the coming years. Here's a detailed overview of the market's size, key players, emerging trends, and important segments shaping its growth.
Projected Market Size of the Gut Microbiota Market by 2030
The…
More Releases for Pharma
Schizophrenia Market Gains Momentum with Expanding Pipeline and Investment Poten …
The Key Schizophrenia Companies in the market include - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Acadia Pharmaceuticals, Boehringer Ingelheim, Cerevel Therapeutics, AstraZeneca, Eli Lilly and Company, Karuna Therapeutics, Neurocrine Biosciences, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2036" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed…
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
